Full Text View
Tabular View
Study Results
Related Studies
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children
This study has been completed.
Study NCT01006629   Information provided by Abbott

First Received on November 2, 2009.   Last Updated on June 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Premature Birth
Bronchopulmonary Dysplasia
Congenital Heart Disease
Additional conditions recognized in this trial
Heart Defects, Congenital
Heart Diseases
Respiratory Syncytial Virus Infections
Virus Diseases
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Mononegavirales Infections
Obstetric Labor Complications
Obstetric Labor, Premature
Paramyxoviridae Infections
Pneumovirus Infections
Pregnancy Complications
Respiratory Tract Diseases
RNA Virus Infections
Ventilator-Induced Lung Injury
Interventions listed in this trial
palivizumab
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services